title: Effects of alpha-lipoic acid on impaired gastric fundus innervation in diabetic rats.
abstract: Diabetes mellitus is a major cause of neuropathy, leading to adverse effects including autonomic gastrointestinal dysfunction. Oxidative stress contributes to the etiology of diabetic neuropathy. The aim was to examine whether treatment with the antioxidant, alpha-lipoic acid (LA), could prevent or correct diabetic functional defects in the gastric fundus non-adrenergic, non-cholinergic (NANC) nerves, which use nitric oxide as their major neurotransmitter. LA (100 mg/kg/d) was given in a prevention study for 8 weeks following streptozotocin-diabetes induction, and in an intervention study for 4 weeks after 4 weeks of untreated diabetes. Fundus strips were studied in vitro after precontraction with 5-hydroxytryptamine in the presence of guanethidine and atropine to isolate NANC relaxation to electrical field stimulation. After 4 and 8 weeks of diabetes, there were 26% and 48% deficits in maximum relaxation, respectively. Prevention LA treatment gave 83% protection; intervention LA prevented the deterioration between 4 and 8 weeks of diabetes and corrected the initial 4 week deficit by 56%. Diabetes also resulted in a failure to maintain relaxation for prolonged stimulation, which was prevented by LA. Thus, LA prevented and reversed the development of impaired gastric fundus NANC responses in diabetic rats, which has potential therapeutic implications for gastrointestinal autonomic neuropathy.
authors.affiliation: Department of Biomedical Sciences, University of Aberdeen, Aberdeen, Scotland, United Kingdom.
authors.forename: T Michael
authors.initials: TM
authors.lastname: Gibson
authors.forename: Mary A
authors.initials: MA
authors.lastname: Cotter
authors.forename: Norman E
authors.initials: NE
authors.lastname: Cameron
mesh_terms: D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000503:physiopathology*; D005748:Gastric Fundus / Q000187:drug effects* / Q000294:innervation* / Q000503:physiopathology; D066298:In Vitro Techniques; D007274:Injections, Intraperitoneal; D008297:Male; D009126:Muscle Relaxation / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects* / Q000294:innervation / Q000503:physiopathology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013311:Streptozocin / Q000494:pharmacology; D008063:Thioctic Acid / Q000494:pharmacology*
chemical_list: D013311:Streptozocin; D008063:Thioctic Acid